CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464097528
- Phone
- 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- 8-K Event Regulation FD disclosure · Other events
- 4 Planned sale EVP, CBO AND CTO sold 103 shares at $10.90 ($1,122)
- 8-K Event Executive or director change
- 4 Planned sale EVP, CBO AND CTO sold 695 shares at $8.21 ($5,706)
- 4 Planned sale EVP, CBO AND CTO sold 139 shares at $8.40 ($1,168)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 4 Planned sale EVP, CBO AND CTO sold 103 shares at $8.82 ($908)
- 4 Planned sale EVP, CBO AND CTO sold 702 shares at $8.59 ($6,033)
- 4 Planned sale EVP, CBO AND CTO sold 141 shares at $8.39 ($1,183)
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award EVP, CHIEF SCIENTIFIC OFFICER acquired 45,167 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale SVP, CHIEF MEDICAL OFFICER sold 4,317 shares at $8.80 ($37,990)
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
Page 10 of 37 · 731 filings